For instance, it was shown that in PTEN-deficient prostate cancer cell lines, inhibition of the PI3K pathway increases androgen receptor signalling, while androgen receptor inhibition activates AKT signalling [29]. The gene discussed is AKT1; the disease is Familial prostate cancer.